Cleared Traditional

K092789 - VIRTUOSAPH PLUS ENDOSCOPIC VESSEL HARVE...

K092789 is an FDA 510(k) clearance for VIRTUOSAPH PLUS ENDOSCOPIC VESSEL HARVE..., manufactured by Terumo Cardiovascular Systems Corp.. The device is a Class 2 General & Plastic Surgery device with product code GCJ cleared through the Traditional 510(k) pathway after a 244-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2010
Decision
244d
Days
Class 2
Risk

K092789 is an FDA 510(k) clearance for the VIRTUOSAPH PLUS ENDOSCOPIC VESSEL HARVESTING SYSTEM. Classified as Laparoscope, General & Plastic Surgery (product code GCJ), Class II - Special Controls.

Submitted by Terumo Cardiovascular Systems Corp. (Ann Arbor, US). The FDA issued a Cleared decision on May 12, 2010 after a review of 244 days - an extended review cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General & Plastic Surgery review framework, consistent with the majority of Class II 510(k) submissions.

View all Terumo Cardiovascular Systems Corp. devices

FDA 510(k) Submission Details - K092789

510(k) Number K092789 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2009
Decision Date May 12, 2010
Days to Decision 244 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 115d · This submission: 244d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GCJ Device Classification - Class 2, Special Controls

Product Code GCJ Laparoscope, General & Plastic Surgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission If The Device Is Reusable And Has Specific Design Features (please Refer To Table 2 Of 82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - GCJ Laparoscope, General & Plastic Surgery

All 789
Devices cleared under the same product code (GCJ) and FDA review panel - the closest regulatory comparables to K092789.
LTF-Y0009
K102379 · Olympus Medical Systems Corporation · Jan 2011
HYBRID TROCAR SYSTEM
K101937 · Aesculap, Inc. · Aug 2010
SINGLE SITE FLEXIBLE BLADELESS OBTURATOR
K101671 · Teleflexmedical, Inc. · Jun 2010
SPECIMEN RETRIEVAL SYSTEM
K100959 · Applied Medical Resources · Apr 2010
LAPAROSCOPIC RETRACTORS
K092684 · Cardinal Health, Inc. · Jan 2010
PAJUNK DISPOSABLE BALLOONS AND BALLOON SYSTEMS
K090631 · PAJUNK GmbH Medizintechnologie · Apr 2009